Voyager Therapeutics’ License Option Agreement with Novartis

WilmerHale advised Voyager Therapeutics on the deal.Voyager Therapeutics, a gene therapy company developing life-changing treatments and next-generation adeno-associated virus (AAV) capsids, announced it entered into a…

This content is for Standard 1 Year members only.
Login Join Now

Advent International’s $6.3 Billion Acquisition of Nuvei

Fidelity National Information Services’ $2.5 Billion Cash Tender Offers

Collaborative Robotics’ $100 Million Series B Financing Round

Gasco’s Project Financing Agreement

Mayakan Gas Pipeline’s Financing Round

MK Properties’ Acquisition of Cyrela Rosa Empreendimentos Imobiliarios

Hokodo’s Debt Financing

Save The Children’s Dismissal of the case in Trapani Criminal Proceedings

Planisware’s Initial Public Offering

India Vehicle Finance’s Notes Offering

KOKO Networks Limited’s Financing Round

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

SC Ventures’ $100 Million Joint Venture With SBI Holdings

GreenCorp’s Acquisition of Emad Bakeries

MedOne’s Agreement with Shikun and Binui Energy

D3 Bio’s $62 Million Series A Financing Round

SingleInterface’s $30 Million Series A Financing Round

Chery’s Joint Venture Agreement with Ebro-EV Motors

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Hefesto Asesores continues to consolidate its position in the International Private Equity and Venture Capital market, with the formation of Hefesto Global

Paul Hastings Adds Premier Private Equity Buyout Team

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Labor and Employment Lawyer Sydney Jones Lampard Joins King & Spalding in Washington, D.C.

Paul Hastings Adds Premier Private Equity Buyout Team

BCLP Appoints Trevor Varnes as Chief Financial Officer

Voyager Therapeutics’ License Option Agreement with Novartis

Author: Martina Bellini